Friday, October 6, 2023

Brief Blog: MolDx to Hold Open LCD Meeting, October 9, 2023 (Thyroid, Lung, Prostate)

On October 9, 2023, MolDx will hold an open comment meeting on several recently announced LCDs or revisions - thyroid, lung, and prostate.

See the general page here and click on the October 9 meeting.

Here's the October 9 agenda:

Open Meeting Notification — Proposed LCD(s) Released for Comment 

  1. MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules DL39646
  2. MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy DL39654  
  3. MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers DL39636

Dates and Durations: MolDxOlogy

The Thyroid LCD is based on a request letter, 1/12/2022.  The pulmonary nodule LCD was "MAC initiated."  The prostate LCD is based on a 2/1/2022 letter.   

Where data is available, the lag between an LCD request and a proposed LCD is about 18 months.   Then, the lag to a final LCD is usually, generally, about 12 months more, for a total of 30 months or 2.5 years from letter to coverage date.


MolDx held a 9/18 meeting on its donor DNA transplant management policy; that transcript is not up yet.